Atlas Trials

A Study Comparing Two Different Capsules, APL-101 and PLB-1001 Capsules, in Healthy Chinese and Caucasian Participants

Clinical trial NCT05367388 · UNKNOWN

Trial details

NCT number
NCT05367388
Sponsor
Apollomics Inc.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2022-05-20
Primary completion
2022-11-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.